8 startups in Newton filed a Form D in the last 12 months. Together they reported $76.2M sold in 6 new rounds. The median round was $8.9M.
Startups
8
filed in 12 months
Reported new funding
$76.2M
6 rounds
Median round
$8.9M
new rounds
Largest rounds
Latest filings
| Company | Industry | Filed | Amount sold | Investors |
|---|---|---|---|---|
| Industrial & Robotics | Nov 10, 2026 | $600K ↗ | 1 | |
| Biotech & Pharma | Aug 13, 2026 | $39.3M ↗ | 23 | |
| Healthcare | Jul 29, 2026 | $18.0M ↗ | 10 | |
| Biotech & Pharma | May 4, 2026 | $13.1M ↗ | 62 | |
| Biotech & Pharma | Apr 23, 2026 | $4.8M ↗ | 37 | |
| Healthcare | Mar 30, 2026 | $300K ↗ | 2 |
Newton companies 26
| Company | Industry | City | Latest filing | Latest raise |
|---|---|---|---|---|
 Walnut Technology CorpA smart thermostat for homeowners. | Industrial & Robotics | Newton | Nov 10, 2026 | $600K |
 Abcuro, Inc.Develops immunotherapies for people with autoimmune diseases and cancer. | Biotech & Pharma | Newton | Aug 13, 2026 | $39.3M |
 Magnendo Corp.Develops robotic guidewires to help physicians reach blood vessels in the brain. | Healthcare | Newton | Jul 29, 2026 | $18.0M |
 Inflammasome Therapeutics, Inc.Develops experimental drugs for people with eye and degenerative diseases. | Biotech & Pharma | Newton | May 4, 2026 | $13.1M |
 General Oncology, Inc.Develops experimental treatments for people with metastatic cancer and other proliferative diseases. | Biotech & Pharma | Newton | Apr 23, 2026 | $4.8M |
 CardioNexa, Inc.Managed cholesterol treatment services for cardiology practices. | Healthcare | Newton | Mar 30, 2026 | $300K |
 GAI Insights Inc.AI research, assessments, and training for private equity firms and other businesses. | Other | Newton | Mar 19, 2026 | $585K |
| Not classified yet | Newton | Jan 27, 2026 | $16.4M | |
| Not classified yet | Newton | Oct 23, 2025 | $3.0M | |
| Not classified yet | Newton | Sep 22, 2025 | $120K | |
| Not classified yet | Newton | Sep 19, 2025 | $40K | |
| Not classified yet | Newton | Sep 2, 2025 | $60K | |
| Biotech & Pharma | Newton | May 22, 2025 | $4.5M | |
| Biotech & Pharma | Newton | May 6, 2025 | $198.1M | |
| Consumer & Retail | Newton | Apr 23, 2025 | $886K | |
| Not classified yet | Newton | Dec 2, 2024 | $5.4M | |
| Not classified yet | Newton | Nov 27, 2024 | $5.0M | |
| Biotech & Pharma | Newton | Sep 3, 2024 | $424K | |
| Biotech & Pharma | Newton | Aug 5, 2024 | $12.6M | |
| Biotech & Pharma | Newton | Jun 26, 2024 | $765K | |
| Not classified yet | Newton | Apr 8, 2024 | $9.1M | |
| Healthcare | Newton | Apr 2, 2024 | $2.8M | |
| Not classified yet | Newton | Dec 8, 2023 | $14.9M | |
| Not classified yet | Newton | Nov 20, 2023 | $205K | |
| Not classified yet | Newton | Aug 22, 2023 | $2.2M | |
| Healthcare | Newton | May 3, 2023 | $12.9M |
How this page is built
Startups are the private companies counted as startups (see our startup funding data), placed by the address on their latest Form D. Registered-agent and virtual-office addresses are not counted as a location. Public companies, foreign issuers and business-combination filings are excluded.